Patient
SITE008-0067
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2025-11-18
Adverse events
10
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 10
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-27 (study day 185); relationship: not assessed
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-04 (study day 131); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-09-30 (study day 127); relationship: not assessed
Grade 2 Hepatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-15 (study day 112); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-09-04 (study day 101); relationship: NOT RELATED
Grade 4 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-08-09 (study day 75); relationship: not assessed; serious criteria: life-threatening
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-07-08 (study day 43); relationship: NOT RELATED
Grade 3 Pruritus — outcome: RECOVERED/RESOLVED; onset 2022-06-30 (study day 35); relationship: not assessed
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-17 (study day 22); relationship: not assessed
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-06-06 (study day 11); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.